1yej: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1yej.jpg|left|200px]] | [[Image:1yej.jpg|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_1yej", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
| | or leave the SCENE parameter empty for the default display. | ||
| | --> | ||
{{STRUCTURE_1yej| PDB=1yej | SCENE= }} | |||
}} | |||
'''CATALYTIC ANTIBODY COMPLEX''' | '''CATALYTIC ANTIBODY COMPLEX''' | ||
| Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YEJ OCA]. | |||
==Reference== | ==Reference== | ||
Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody., Gigant B, Charbonnier JB, Eshhar Z, Green BS, Knossow M, J Mol Biol. 1998 Dec 4;284(3):741-50. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/9826512 9826512] | Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody., Gigant B, Charbonnier JB, Eshhar Z, Green BS, Knossow M, J Mol Biol. 1998 Dec 4;284(3):741-50. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/9826512 9826512] | ||
[[Category: Gigant, B.]] | [[Category: Gigant, B.]] | ||
[[Category: Knossow, M.]] | [[Category: Knossow, M.]] | ||
[[Category: | [[Category: Abzyme]] | ||
[[Category: | [[Category: Transition state analog]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 16:13:35 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
Revision as of 16:13, 3 May 2008
CATALYTIC ANTIBODY COMPLEX
OverviewOverview
The antibody D2.3 catalyzes the hydrolysis of several p-nitrobenzyl and p-nitrophenyl esters with significant rate enhancement; product inhibition is observed with the former compounds but not with the latter. Whereas enzyme specificity has been extensively studied by X-ray crystallography, structural data on catalytic antibodies have thus far related only to one of the reactions they catalyze. To investigate the substrate specificity and the substrate relative to product selectivity of D2.3, we have determined the structures of its complexes with two p-nitrophenyl phosphonate transition state analogs (TSAs) and with the reaction product, p-nitrophenol. The complexes with these TSAs, determined at 1.9 A resolution, and that with p-nitrobenzyl phosphonate determined previously, differ mainly by the locations and conformations of the ligands. Taken together with kinetic data, the structures suggest that a hydrogen bond to an atom of the substrate distant by eight covalent bonds from the carbonyl group of the hydrolyzed ester bond contributes to catalytic efficiency and substrate specificity. The structure of Fab D2.3 complexed with p-nitrophenol was determined at 2.1 A resolution. Release of p-nitrophenol is facilitated due to the unfavourable interaction of the partial charge of the nitro group of p-nitrophenolate with the hydrophobic cavity where it is located, and to the absence of a direct hydrogen bond between the product and the Fab. Catalytic specificity and the manner of product release are both affected by interactions with substrate atoms remote from the reaction center that were not programmed in the design of the TSA used to elicit this antibody. Selection of a catalytic antibody that makes use of TSA unprogrammed features has been made practical because of the screening for catalytic efficiency incorporated in the procedure used to obtain it.
About this StructureAbout this Structure
Full crystallographic information is available from OCA.
ReferenceReference
Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody., Gigant B, Charbonnier JB, Eshhar Z, Green BS, Knossow M, J Mol Biol. 1998 Dec 4;284(3):741-50. PMID:9826512 Page seeded by OCA on Sat May 3 16:13:35 2008